Hospital de Clinicas de Porto Alegre - Centro de Pesquisa Clinica

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Follicular lymphoma1 trial
• Ulcerative colitis1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Epizyme, Inc.1 trial
• InDex Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

  NCT04224493· Phase 3· Epizyme, Inc.· Source

Closed trials

• Terminated

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· Phase 3· InDex Pharmaceuticals· Source